These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. Bielski RJ, Ventura D, Chang CC. J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045 [Abstract] [Full Text] [Related]
9. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. JAMA; 2000 Jun 21; 283(23):3082-8. PubMed ID: 10865302 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group. Thase ME. J Clin Psychiatry; 1997 Sep 21; 58(9):393-8. PubMed ID: 9378690 [Abstract] [Full Text] [Related]
13. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM, Llorca PM, Despiegel N, Verpillat P. Encephale; 2004 Sep 21; 30(2):158-66. PubMed ID: 15107719 [Abstract] [Full Text] [Related]
14. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study. Kaplan EM. Clin Ther; 2002 Jul 21; 24(7):1194-200. PubMed ID: 12182262 [Abstract] [Full Text] [Related]
15. Escitalopram versus venlafaxine XR in the treatment of depression. Montgomery SA, Andersen HF. Int Clin Psychopharmacol; 2006 Sep 21; 21(5):297-309. PubMed ID: 16877901 [Abstract] [Full Text] [Related]